How will the Supreme Court’s mifepristone decision impact biopharma?

Off Biotech, biotechnology, coronavirus, drug development, drug prices, drug pricing, FDA, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, public health, research, Science and Research, The Readout, vaccines

New biotech newsletter launching this Thursday. Don’t miss out.

Hey there. Today, we discuss the implications of the Supreme Court’s forthcoming mifepristone evaluation on the FDA and the biopharma industry. We also examine how Covid-19 vaccine makers are faring today, and more.

Read the rest…

Read Original Article: How will the Supreme Court’s mifepristone decision impact biopharma? »

About The Author